UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of December 2021
Commission File Number: 001-40414
Skylight Health Group Inc.
(Exact name of Registrant as specified in its charter)
5520 Explorer Drive, Suite 402
Mississauga, Ontario L4W 5L1
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INCORPORATION BY REFERENCE
Exhibits 99.1 and 99.3 of this Form 6-K are incorporated by reference as a additional exhibits to the registrant’s Registration Statement on Form F-10 (File No. 333-255444).
DOCUMENTS INCLUDED AS PART OF THIS REPORT
Exhibit | ||
99.1 | Material Change Report dated December 7, 2021 | |
99.2 | Underwriting Agreement dated December 1, 2021 | |
99.3 | Consent of Ellenoff Grossman & Schole LLP | |
99.4 | Consent of Gardiner Roberts LLP | |
99.5 | Consent of Grant Thornton LLP |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Skylight Health Group Inc. | ||||||
(Registrant) | ||||||
Date: December 7, 2021 | /s/ Pradyum Sekar | |||||
Pradyum Sekar | ||||||
Chief Executive Officer and Director |